Quercetin and MicroRNA Interplay in Apoptosis Regulation in Ovarian Cancer

Author(s): Khushbukhat Khan, Zeeshan Javed*, Haleema Sadia, Javad Sharifi-Rad*, William C. Cho*, Claudio Luparello*

Journal Name: Current Pharmaceutical Design

Volume 27 , Issue 20 , 2021

Become EABM
Become Reviewer
Call for Editor


The multifaceted nature of ovarian cancer has severely hampered the development of effective therapeutics over the years. The complicate nature of ovarian cancer makes it therapeutically challenging, therefore, there has been a renewed interest in phytochemistry. Phytochemicals have emerged as a potential therapeutic option due to less side effects. Moreover, the signaling inhibition properties have also been studied extensively in recent times. A growing number of data obtained via high-throughput technologies has started to delineate the complex oncogenic signaling networks, thus broadening the therapeutic opportunities. Within the network, microRNAs (miRNAs) have been shown to play a versatile role in the regulation of cancer. Quercetin has been in the spotlight over the years because of its high pharmacological values and substantial evidence has demonstrated its anti-proliferative effect against various types of cancers. Despite the versatility of quercetin, little is known about its anti-proliferative potential towards ovarian cancer. This review sheds some light on quercetin as an alternative therapeutic approach to cancer. Furthermore, we also addresss the interplay between miRNAs and quercetin in the regulation of apoptosis in ovarian cancer.

Keywords: Quercetin, ovarian cancer, chemo-preventive agent, apoptosis, miRNAs, phytochemicals.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 18 October, 2020
Page: [2328 - 2336]
Pages: 9
DOI: 10.2174/1381612826666201019102207
Price: $65

Article Metrics

PDF: 205